Terrestrial ecotoxicological studies for veterinary pharmaceuticals in livestock dung in the field: Phase II Tier A and beyond

By Jörg Römbke2022-03-21T09:45:00

Source: Adobe Stock

The environmental risk from veterinary pharmaceuticals (VPs), which are usually called veterinary medical products (VMPs) must be assessed according to European legislation: in particular, parasiticides that are used for pastured animals (eg, sheep, cattle etc). This is especially true regarding the non-target effects of faecal residues on dung-dwelling organisms. Focusing ...

How to read this journal article

Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to registered users and TOPRA members.

Already a member or have an account? Sign in.

1. REGISTER FOR FREE

Free access to selected content

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

Create your own library to save your favourite content.

Create a free account

2. Members login

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.

3. JOIN TOPRA

Special offer on
TOPRA membership

Join TOPRA today and get membership until the end of 2025 for the exclusive rate of £290.

In addition to unlimited access to Regulatory Rapporteur content, as a TOPRA member you will also be able to enjoy a wide range of benefits including career boosting resources, savings on our events and training, and access to our regional networks and special interest groups.

This offer ends 31 July 2024

Become a member